SelectQuote Stock Earnings Estimates Cut by Noble Financial

Key Points

• Noble Financial lowered its Q2 2027 EPS estimate for SelectQuote to $0.11 from $0.12; the current full-year consensus forecast is a loss of $0.20 per share.
• SelectQuote’s latest quarter beat expectations, reporting a $0.21-per-share loss versus the $0.33 loss analysts expected, and revenue of $280.01 million versus a $277.91 million estimate.
• Analyst sentiment is mixed, with a consensus “Hold” rating and a $3.00 target price. The stock opened at $0.39 and was reported down 20%.

SelectQuote, Inc. (NYSE:SLQT - Free Report) - Equities research analysts at Noble Financial dropped their Q2 2027 earnings per share (EPS) estimates for shares of SelectQuote in a research report issued on Thursday, November 5th. Noble Financial analyst M. Kupinski now expects that the company will earn $0.11 per share for the quarter, down from their prior estimate of $0.12. The consensus estimate for SelectQuote's current full-year earnings is ($0.20) per share.

A number of other research firms also recently commented on SLQT. Wall Street Zen downgraded shares of SelectQuote from a "hold" rating to a "sell" rating in a research report on Saturday, August 29th. Weiss Ratings cut shares of SelectQuote from a "sell (d+)" rating to a "sell (d)" rating in a research report on Monday, August 17th. Finally, Zacks Research raised shares of SelectQuote from a "strong sell" rating to a "hold" rating in a research report on Monday, October 26th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $3.00.

SelectQuote Stock Down 20.0%

NYSE:SLQT opened at $0.39 on Friday. The company has a debt-to-equity ratio of 1.16, a current ratio of 7.48 and a quick ratio of 6.57. SelectQuote has a 1-year low of $0.30 and a 1-year high of $1.90. The company has a 50-day moving average of $0.42 and a 200 day moving average of $0.76. The firm has a market cap of $70.45 million, a PE ratio of -13.10 and a beta of 2.01.

SelectQuote (NYSE:SLQT - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.12. The firm had revenue of $280.01 million for the quarter, compared to analyst estimates of $277.91 million. SelectQuote had a return on equity of 22.48% and a net margin of 4.61%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Commonwealth Equity Services LLC raised its holdings in SelectQuote by 541.1% in the third quarter. Commonwealth Equity Services LLC now owns 181,939 shares of the company's stock worth $74,000 after purchasing an additional 153,562 shares in the last quarter. SMH Capital Advisors Inc. purchased a new stake in shares of SelectQuote during the third quarter valued at about $47,000. Fragasso Financial Advisors Inc purchased a new stake in shares of SelectQuote during the third quarter valued at about $61,000. Squarepoint Ops LLC purchased a new stake in shares of SelectQuote during the second quarter valued at about $536,000. Finally, Hsbc Holdings PLC boosted its holdings in shares of SelectQuote by 850.0% in the 2nd quarter. Hsbc Holdings PLC now owns 122,430 shares of the company's stock valued at $102,000 after buying an additional 109,543 shares in the last quarter. 34.59% of the stock is owned by institutional investors.

About SelectQuote

SelectQuote, Inc NYSE: SLQT operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs.

SelectQuote's primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.